An SGLT2 inhibitor and two fixed-dose combinations will be available in January and February 2018 The FDA has approved three new drugs for type-2 diabetes:...
An SGLT2 inhibitor and two fixed-dose combinations will be available in January and February 2018 The FDA has approved three new drugs for type-2 diabetes:...
